allulose sweetener glp 1 Is a GLP-1 Agonist? Evidence and Key Differences ALLULOSE-NOT INTERESTED IN TAKING SEMAGLUTIDE-TRY
Description
Conclusion The emergence of lower-cost GLP-1 therapies could mark a major turning point in diabetes management
For diabetes management, semaglutide is typically initiated at 0.25 mg subcutaneously once weekly, with gradual dose escalation to a maintenance dose of 0.5 mg to 2 mg weekly
Patients and doctors should be extra vigilant if the patient has other risk factors for blood clots
"The lowest doses of these medications are usually given at first and then gradually increased so people have less chance of developing side effects," he says
